Serving a biotech team in bringing the message and science of the latest drug for weight-loss and diabetes.
Gelesis100 (now called Plenity® )
Gelesis100 is a first-in-class therapeutic device which is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. It is administered orally as a capsulated device. Gelesis100 is designed to trigger several important weight loss mechanisms in the stomach and small intestine.
CEO & Founder, Gelesis, Inc., Boston, USA
Developing interactive media for iPad, for a healthcare communications agency & a pharmaceutical company.
+44 (0) 20 7183 9412 - UK
+1 646 568 4358 - USA
Suite 6, Claremont House,
22-24, Claremont Rd.,
KT6 4QU, UK